With Alcon bid, Novartis sets sights on aging consumer
Marc Iskowitz
January 06 2010
Novartis' bid for full ownership of Alcon could spawn an eye-care behemoth with a consumer-products unit worth about $1 billion.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.